Free CME from PeerView


Oncology CME

PVI, PeerView Institute for Medical Education
Real-World Nursing Solutions for AML Care: Insights on the Effective and Safe Delivery of Innovative Therapeutics
Laura J. Zitella, MS, RN, ACNP-BC, AOCN
February 27, 2023
PVI, PeerView Institute for Medical Education
Perfecting Precision in Modern NSCLC Practice: Are You Optimally Integrating Biomarker-Driven Therapy?
Stephen V. Liu, MD
February 26, 2023
PVI, PeerView Institute for Medical Education
Peer Pressure: How Well Do You Know Your ADCs? Answers to Key Questions About Antibody–Drug Conjugates in NSCLC
Benjamin Levy, MD
February 23, 2023
PVI, PeerView Institute for Medical Education
Facilitating Progress in the Treatment of SCLC: How to Optimize the Use of Current Systemic Options and Accelerate the Clinical Transition of Investigational Approaches
Jacob Sands, MD
February 22, 2023
PVI, PeerView Institute for Medical Education
Addressing Key Questions About the Latest Diagnostic and Therapeutic Advances in Desmoid Tumors
Ravin Ratan, MD, M.Ed
February 22, 2023
PVI, PeerView Institute for Medical Education
Refining Precision Decisions in NSCLC With Common and Less Common EGFR Mutations: Navigating Testing and Treatment Throughout the Disease Continuum
Natasha B. Leighl, MD, MMSc, FRCPC, FASCO
February 22, 2023
PVI, PeerView Institute for Medical Education
Expanding Use of Hormonal Therapeutic Strategies in Prostate Cancer: Clinical Evidence and Practical Considerations for Individualized, Patient-Centered Care
Matthew R. Smith, MD, PhD
February 17, 2023
PVI, PeerView Institute for Medical Education
Fresh Perspectives on Moving Toward Personalized Care for Bladder Cancer: Tips, Tools, and Strategies for Leveraging the Latest Advancements Across the Disease Spectrum
Matthew I. Milowsky, MD, FASCO
February 16, 2023
PVI, PeerView Institute for Medical Education
Essential Conversations for HCC: Radiology-Oncology Collaboration and Immunotherapy Advances in Intermediate and Advanced Disease
Riad Salem, MD, MBA / Mark Yarchoan, MD
February 15, 2023
The Medical College of Wisconsin
Hitting the BCMA Target in Multiple Myeloma: Insights on CAR-T Therapy and Innovative Antibody Options
Thomas G. Martin, III, MD / Krina Patel, MD, MSc
February 14, 2023
PVI, PeerView Institute for Medical Education
New Horizons for Advanced Endometrial Cancer Treatment: Utilizing Innovative Immunotherapies and Other Novel Approaches
Shannon N. Westin, MD, MPH
February 06, 2023
PVI, PeerView Institute for Medical Education
Innovation Now for Follicular Lymphoma: New Evidence for Immunotherapy, Targeted, and Chemo-Free Options
Loretta J. Nastoupil, MD
February 01, 2023
PVI, PeerView Institute for Medical Education
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
John C. Byrd, MD
February 01, 2023
PVI, PeerView Institute for Medical Education
Building a Safety-Centric Culture in B-Cell Cancers: Interprofessional Insights on Optimizing BTKi Efficacy Through Safety Management
Nicole Lamanna, MD
January 30, 2023
PVI, PeerView Institute for Medical Education
Fine-Tuning Biomarker Testing to Identify and Target RET Fusions as Uncommon But Actionable Genomic Alterations in NSCLC
Nathan A. Pennell, MD, PhD, FASCO
January 29, 2023
PVI, PeerView Institute for Medical Education
Getting Personal With Advanced BTC: Insights on Personalizing Upfront and Sequential Care With Immunotherapy and Targeted Agents
Rachna T. Shroff, MD, FASCO
January 20, 2023
PVI, PeerView Institute for Medical Education
Realizing the Promise of Perioperative Immunotherapy in Resectable NSCLC: How to Modernize Best Practices Based on New Evidence and Better Multidisciplinary Alliances
Nasser Altorki, MD / Jonathan D. Spicer, MD, PhD, FRCSC
January 20, 2023
PVI, PeerView Institute for Medical Education
Seek and You Will Find in Advanced GI Cancers: Identifying and Targeting Uncommon but Actionable Genomic Alterations in Colorectal, Pancreatic, and Other Cancers
Vivek Subbiah, MD
January 19, 2023
PVI, PeerView Institute for Medical Education
The HCC Revolution Continues: Exploring Evidence-Based Treatment Selection and Sequencing in Advanced Disease and Beyond
Ghassan Abou-Alfa, MD, MBA
January 19, 2023
PVI, PeerView Institute for Medical Education
Changing Times for Hemophilia: Exploring Evidence With Novel and Emerging Nonfactor Therapies
Steven W. Pipe, MD
December 29, 2022
Medical Learning Institute, Inc.
New Evidence Now for Targeted Therapy in TGCT
Prof. Hans Gelderblom, MD
December 22, 2022
PVI, PeerView Institute for Medical Education
Critical Conversations on Venous Thromboembolism: A MasterClass Series on DVT and PE
Alexander (Ander) T. Cohen, MBBS, MSc, MD, FRACP, FESC, FRCP
December 15, 2022
Penn State College of Medicine
The Sequel to the Targeted Therapy Era in CML: Guidance on Integrating Novel Options Into Cohesive Sequential Care
Vivian G. Oehler, MD
December 08, 2022
PSU, Penn State University
Fixing the Target on Aggressive Lymphoma: Guidance on the Next Phase of Integrating Targeted Agents Into MCL and DLBCL Management
Dr. Toby A. Eyre, MBChB, DipMedEd, MRCP, FRCPath, MD
December 08, 2022
PSU, Penn State University
The Rising Tide of CAR-T in Lymphoma: Guidance on Leveraging Cellular Therapy to Improve Outcomes Across the Spectrum of Care
Jason Westin, MD, MS, FACP
December 08, 2022
Medical Learning Institute, Inc.
The Winning Way With BTK Inhibitors in CLL: Evidence-Informed Choices on Treatment Selection, Safety, and Therapeutic Sequencing
John C. Byrd, MD
December 08, 2022
Medical Learning Institute, Inc.
The Road to Remission in Multiple Myeloma: Expert Guidance on Using BCMA-Targeted Options to Enhance Clinical Outcomes
Nikhil C. Munshi, MD
December 08, 2022
PSU, Penn State University
The Future is Now in MDS: Integrating Innovative, Risk-Adapted Therapies Into Patient Management
Guillermo Garcia-Manero, MD
December 08, 2022
PSU, Penn State University
Fine-Tuning the Wave of Innovation in CLL: Personalized Models for Upfront and Sequential Care With Groundbreaking Treatment
Prof. John G. Gribben, MD, DSc
December 08, 2022
Penn State College of Medicine
Real-World, Real Innovation in DLBCL: Perspectives on Integrating Novel Antibody Platforms Into Patient Care
Grzegorz (Greg) Nowakowski, MD
December 08, 2022

Pages

Upcoming Live Events

Education Collections

More Education Collections

Recent CME Podcast

More Podcasts from PeerView